Exactly right. Nobody is interested in bisantrene as a less cardiotoxic alternative to doxorubicin, they are interested because they can keep using doxorubicin and gain the potential of cardioprotection and increased anticancer activity.
While the data Moleculin have presented is very interesting, the market doesn't seem to care and their MC is only US$10m.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-406
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.035(2.18%) |
Mkt cap ! $266.3M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.56 | $101.6K | 64.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7451 | $1.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 408 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7451 | 1.550 |
1 | 1136 | 1.525 |
2 | 3429 | 1.520 |
1 | 30000 | 1.510 |
2 | 5000 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 408 | 1 |
1.615 | 53378 | 1 |
1.620 | 278 | 1 |
1.650 | 5000 | 1 |
1.700 | 3424 | 5 |
Last trade - 15.53pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.58 |
  |
Change
-0.035 ( 1.25 %) |
|||
Open | High | Low | Volume | ||
$1.58 | $1.62 | $1.56 | 7255 | ||
Last updated 15.57pm 05/06/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online